Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $4.64 and traded as low as $2.92. Hypera shares last traded at $2.92, with a volume of 2,091 shares trading hands.
Hypera Stock Performance
The business has a 50 day moving average of $3.62 and a 200-day moving average of $4.64. The company has a market capitalization of $1.85 billion, a P/E ratio of 5.38 and a beta of 1.02.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- Investing in Commodities: What Are They? How to Invest in Them
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 2 Drone Stocks Surging from Increased Media Attention
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
